But the U.S. pharma giant and its German partner Boehringer Ingelheim won a big victory on Friday as the Food ad Drug Administration (FDA) approved their diabetes drug Jardiance as a treatment to reduce the risk of heart attack, stroke, and other cardiovascular events in type 2 diabetes patients. (fortune.com)
People taking codeine appeared to have a higher risk of heart attack and other cardiovascular events compared to those taking hydrocodone, the study found. (health.com)
In May 2007, the FDA has issued a safety alert regarding the risk of heart attacks and other cardiovascular events when taking Avandia. (verywellhealth.com)